Skip Navigation



Human Molecular Genetics Advance Access published online on June 21, 2007

Human Molecular Genetics, doi:10.1093/hmg/ddm145
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrowOA All Versions of this Article:
16/21/2529    most recent
ddm145v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Demura, M.
Right arrow Articles by Bulun, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demura, M.
Right arrow Articles by Bulun, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Regional Rearrangements in Chromosome 15q21 Cause Formation of Cryptic Promoters for the CYP19 (Aromatase) Gene

Masashi Demura1,{dagger}, Regina M. Martin1,2,{dagger}, Makio Shozu3, Siby Sebastian4, Kazuto Takayama5, Wei-Tong Hsu6, Roger A. Schultz7, Kirk Neely8, Michael Bryant9, Berenice B. Mendonca2, Keiichi Hanaki10, Susumu Kanzaki10, David B. Rhoads11, Madhusmita Misra11 and Serdar E. Bulun1,*

1 Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611 2 Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Divisao de Endocrinologia, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 01065-970, Brazil 3 Department of Obstetrics and Gynecology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan 4 Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710 5 Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai 980-8574, Japan 6 Department of Pediatrics, Rush Medical School, Chicago, Illinois 60612 7 Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 8 Department of Pediatrics, Stanford University, Palo Alto, California 94305 9 Department of Pediatrics, Children's Hospital, Los Angeles, California 90027 10 Division of Pediatrics and Perinatology, Tottori University, Yonago, Japan 11 Pediatric Endocrine Unit, Mass General Hospital for Children and Harvard Medical School, Boston, Massachusetts 02114

* Corresponding author: Serdar E. Bulun, MD, Division of Reproductive Biology Research, Northwestern University Feinberg School of Medicine, 303 E. Superior Street, Suite 4-123, Chicago, IL 60611 USA. Tel: 312-503-0520, Fax: 312-503-0095, e-mail: s-bulun{at}northwestern.edu

Received March 29, 2007; Revised June 5, 2007; Accepted June 5, 2007

Production of appropriate quantities of estrogen in various tissues is essential for human physiology. A single gene (CYP19), regulated via tissue-specific promoters, encodes the enzyme aromatase, which catalyzes the key step in estrogen biosynthesis. Aromatase excess syndrome is inherited as autosomal dominant and characterized by high systemic estrogen levels, short stature, prepubertal gynecomastia and testicular failure in males, and premature breast development and uterine pathology in females. The underlying genetic mechanism is poorly understood. Here, we characterize 5 distinct heterozygous rearrangements responsible for aromatase excess syndrome in 3 unrelated families and 2 individuals (9 patients). The constitutively active promoter of one of five ubiquitously expressed genes located within the 11.2-Mb region telomeric to the CYP19 gene in chromosome 15q21 cryptically upregulated aromatase expression in several tissues. Four distinct inversions reversed the transcriptional direction of the promoter of a gene (CGNL1, TMOD3, MAPK6 or TLN2), placing it upstream of the CYP19 coding region in the opposite strand, whereas a deletion moved the promoter of a fifth gene (DMXL2), normally transcribed from the same strand, closer to CYP19. The proximal breakpoints of inversions were located 17 to 185 kb upstream of the CYP19 coding region. Sequences at the breakpoints suggested that the inversions were caused by intrachromosomal nonhomologous recombination. Splicing the untranslated exon downstream of each promoter onto the identical junction upstream of the translation initiation site created CYP19 mRNA encoding functional aromatase protein. Taken together, small rearrangements may create cryptic promoters that direct inappropriate transcription of CYP19 or other critical genes.


{dagger} Both authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.